Cassava Sciences Corporate Update Scheduled for November 25th
Cassava Sciences is gearing up for an exciting Corporate Update on November 25th! They are a biotech company on a mission to tackle neurodegenerative diseases like Alzheimer’s. If you want to tune in to their latest news, mark your calendar for Monday, November 25th at 8:00 a.m. Eastern Time. You can catch the webcast at https://lifescievents.com/event/cassava/. And don’t worry if you miss it – a replay will be available on the Company Presentations page of the Cassava Sciences website for 90 days after the event.
This up-and-coming biotechnology company based in Austin, Texas is making waves with its investigational oral drug candidate, Simufilam. Currently in Phase 3 clinical trials, Simufilam is showing promise in potentially treating Alzheimer’s disease by targeting the filamin A protein. It’s exciting to see innovative treatments like this on the horizon!
If you want to learn more about Cassava Sciences and their groundbreaking work, check out their website at https://www.CassavaSciences.com. And for any investor or media inquiries, you can contact them at [email protected] or [email protected], respectively.
This Corporate Update is just one step in Cassava Sciences’ journey to fight Alzheimer’s disease. Stay tuned for more exciting news from this dedicated team.
